BioProcess International Europe - Cell Line Development

April 2–5, 2019
Vienna, Austria

Meet Genedata experts at the BioProcess International Europe in Vienna, Austria.

Don't miss the opportunity to see how the Genedata Bioprocess® workflow system improves process quality and efficiency of large-molecule development and CMC activities by streamlining and automating complex workflows in cell line development, upstream and downstream process development, drug formulation, and analytical development.

To schedule a meeting in advance, please contact Genedata at

Recommended Oral Presentations

Adapting Cell Line and Clone Selection Methods and Workflows for Continuous Manufacturing
Christine DeMaria, Director, Cell Line Development, Sanofi

Cell Line Development & Engineering
Wednesday, April 3 | 9:00–9:30

Making the Most Out of the Data Collected along the CLD Process
Anke Mayer-Bartschmid, PhD, Cell and Protein Sciences, Pharmaceuticals Division, Bayer Pharma

High titers and good product quality are the key features a final production cell line needs to have. Besides many other quality attributes a consistent track record and data integrity are essential to launch the cell line for production. Furthermore, the availability of screening data during cell line development allows for fast analysis and the selection of the best clones. We will present Bayer’s way for tracking and analysis of clone selection data.

Cell Line Development & Engineering
Wednesday, April 3 | 16:15–16:45

End-to-end Workflow Platform to Speed Up Cell Line Development at Highest Quality Standards
Christoph Freiberg, Ph.D., Senior Scientific Consultant, Bioprocess, Genedata

Cell Line Development & Engineering
Wednesday, April 3 | 14:15–14:45

We have developed an E2E platform that supports the entire bioprocess development workflow by automating cell line development and managing upstream process (USP), downstream process (DSP), analytical and formulation development. The system directly integrates with instruments and enables informed decision-making via its query and reporting infrastructure. We present efficiency and quality gains obtained using the cell line and upstream process development modules of the platform

Poster Presentations

A Platform Approach to Decrease Developability & Manufacturability Risks of Biologics Molecules

High-throughput Screening for Best Manufacturing of Cell Lines using Scale-down Models